Study of Neoadjuvant Ipilimumab in Patients With Urothelial Carcinoma Undergoing Surgical Resection
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn if ipilimumab can be given safely at two different
doses given to patients with urothelial cancer who are going to have surgery as part of their
treatment. The immunological effectiveness of ipilimumab will also be studied.